InnoCare Pharmaceutical Co., Ltd. will host the 2021 R&D Day event on April 15, 2021

March 15, 2021, Beijing, China - InnoCare Pharmaceutical Co., Ltd. (Hong Kong Stock Exchange Code: 09969) announced today that the company will hold an R&D Day event with the theme of "Science-Driven Innovation" in Beijing from 9:00 am to 12:00 am on April 15, 2021. InnoCare Pharmaceutical Co., Ltd.’s management team will share the company’s latest R&D, preclinical and clinical trial progress with investors.

Interested investors can submit registration information by scanning the QR code below.

About InnoCare Pharmaceutical Co., Ltd.

InnoCare Pharmaceutical Co., Ltd. (Hong Kong Stock Exchange Code: 09969) is a biopharmaceutical high-tech company in the commercialization stage. It focuses on the development of new drugs in the field of treatment of malignant tumors and autoimmune diseases. It is suitable for a variety of malignant tumors and autoimmune diseases such as lymphoma, liver cancer, cholangiocarcinoma, and urothelial cancer that are highly prevalent in Chinese patients. There are currently multiple new drug products in the commercialization, clinical and preclinical development stages. The company has branches in Beijing, Nanjing, Shanghai, Guangzhou, New Jersey and Boston in the United States.